Clinical Trial Update: A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

View source ↗

Summary

This clinical trial update reports on a pharmacogenomics study in breast cancer patients undergoing adjuvant chemotherapy with doxorubicin/cyclophosphamide and/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxol (paclitaxel)

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Status: COMPLETED